628 matches for your search in the start-up spotlight
rss
Antibiotic-free protein production: Our Pop-Out-PlasmidTM Technology allows to produce recombinant proteins in E. coli without any selection marker (antibiotic-free) and without adding an inducer like IPTG. As a plus, our technology decouples growth and production stages.
Humify has developed a breakthrough process to convert biomass into artificial humic substances. The efficiency of this continuous process enables scaling up on a global scale to restore fertile soils with significantly increased carbon sequestration. The production and application of Humify ...
Humify has developed a breakthrough process to convert biomass into artificial humic substances. The efficiency of this continuous process enables scaling up on a global scale to restore fertile soils with significantly increased carbon sequestration. The production and application of Humify ...
Humify has developed a breakthrough process to convert biomass into artificial humic substances. The efficiency of this continuous process enables scaling up on a global scale to restore fertile soils with significantly increased carbon sequestration. The production and application of Humify ...
AI-Powered Drug Discovery for Medicinal & Computational Chemists through our flagship CHEESE platform. Our flagship CHEESE Molecular Search (Chemical Embeddings Search Engine) transforms virtual high-throughput screening (vHTS). It screens billions of compounds (Enamine REAL, Chemriya or your ...
Cytocast is a data-driven biotechnology company, providing a cell simulation platform, that can revolutionize how we treat patients starting from drug discovery and development (Cytocast Digital Twin Cell™) to selecting the best treatment option for patients (Cytocast Digital Twin Patient™).
Founded in January 2024, Toleris Biotherapeutics is a pioneering biotech company based in Würzburg, Germany. Led by an experienced team of scientists and entrepreneurs, we specialize in developing first-in-class AutoImmunity Modifying Biologics (AIM Bios) - a breakthrough therapeutic approach ...
NUCLIDIUM AG is a clinical-stage biotechnology company pioneering the development of next-generation copper-based radiopharmaceuticals for the diagnosis and treatment of cancer. Leveraging copper isotopes – Copper-61 for diagnostics and Copper-67 for therapeutics – NUCLIDIUM is creating a ...
Neoclease is a biotechnology company pioneering AI-designed gene-editing therapies optimized for individual genes. Using a proprietary platform that integrates generative protein models with synthetic biology, Neoclease builds ultra-precise, delivery-ready nucleases for diseases with high unmet ...
Mosanna Therapeutics is a clinical-stage biotech company pioneering a novel pharmaceutical approach to treating obstructive sleep apnea (OSA) with an easily administered nasal spray. Designed to help restore the body’s natural airway control during sleep, Mosanna’s lead therapy, MOS118, offers a ...
